2457958

Source:http://linkedlifedata.com/resource/pubmed/id/2457958

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016441, umls-concept:C0027651, umls-concept:C0030705
pubmed:issue	6
pubmed:dateCreated	1988-10-6
pubmed:language	ger
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0407224
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0040-5930
pubmed:author	pubmed-author:SauterCC
pubmed:issnType	Print
pubmed:volume	45
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	393-6
pubmed:dateRevised	2008-2-12
pubmed:meshHeading	pubmed-meshheading:2457958-Antineoplastic Agents, pubmed-meshheading:2457958-Female, pubmed-meshheading:2457958-Follow-Up Studies, pubmed-meshheading:2457958-Health Expenditures, pubmed-meshheading:2457958-Humans, pubmed-meshheading:2457958-Male, pubmed-meshheading:2457958-Neoplasm Recurrence, Local, pubmed-meshheading:2457958-Neoplasms, pubmed-meshheading:2457958-Palliative Care
pubmed:year	1988
pubmed:articleTitle	[Follow-up studies of tumor patients: what is reasonable today?].
pubmed:publicationType	Journal Article, English Abstract